.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Boehringer Ingelheim
Fish and Richardson
Citi
US Department of Justice
Moodys
Express Scripts
Farmers Insurance
Healthtrust
Accenture

Generated: November 22, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: amphetamine

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Neos Theraps Inc
ADZENYS ER
amphetamine
SUSPENSION, EXTENDED RELEASE;ORAL204325NDANeos Therapeutics, LP70165-003-15450 mL in 1 BOTTLE, GLASS (70165-003-15)
Neos Theraps
ADZENYS XR-ODT
amphetamine
TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL204326NDANeos Therapeutics, LP70165-005-3030 BLISTER PACK in 1 CARTON (70165-005-30) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
Neos Theraps
ADZENYS XR-ODT
amphetamine
TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL204326NDANeos Therapeutics, LP70165-010-3030 BLISTER PACK in 1 CARTON (70165-010-30) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
Neos Theraps
ADZENYS XR-ODT
amphetamine
TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL204326NDANeos Therapeutics, LP70165-015-3030 BLISTER PACK in 1 CARTON (70165-015-30) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
Neos Theraps
ADZENYS XR-ODT
amphetamine
TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL204326NDANeos Therapeutics, LP70165-020-3030 BLISTER PACK in 1 CARTON (70165-020-30) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
Neos Theraps
ADZENYS XR-ODT
amphetamine
TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL204326NDANeos Therapeutics, LP70165-025-3030 BLISTER PACK in 1 CARTON (70165-025-30) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
Neos Theraps
ADZENYS XR-ODT
amphetamine
TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL204326NDANeos Therapeutics, LP70165-030-3030 BLISTER PACK in 1 CARTON (70165-030-30) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
Tris Pharma Inc
DYANAVEL XR
amphetamine
SUSPENSION, EXTENDED RELEASE;ORAL208147NDATris Pharma Inc27808-102-01464 mL in 1 BOTTLE (27808-102-01)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
AstraZeneca
Boehringer Ingelheim
Julphar
McKesson
Daiichi Sankyo
Johnson and Johnson
Covington
Cipla
Fuji

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot